These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33625603)

  • 1. Research activity amongst DCM research priorities.
    Grodzinski B; Bestwick H; Bhatti F; Durham R; Khan M; Partha Sarathi CI; Teh JQ; Mowforth O; Davies B
    Acta Neurochir (Wien); 2021 Jun; 163(6):1561-1568. PubMed ID: 33625603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of quality of life in degenerative cervical myelopathy: a systematic review.
    Hirayama Y; Mowforth OD; Davies BM; Kotter MRN
    Br J Neurosurg; 2023 Feb; 37(1):71-81. PubMed ID: 34791981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Inefficiency in Degenerative Cervical Myelopathy: Findings of a Systematic Review on Research Activity Over the Past 20 Years.
    Mowforth OD; Davies BM; Goh S; O'Neill CP; Kotter MRN
    Global Spine J; 2020 Jun; 10(4):476-485. PubMed ID: 32435569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tremor as a symptom of degenerative cervical myelopathy: a systematic review.
    El Khoury M; Mowforth OD; El Khoury A; Partha-Sarathi C; Hirayama Y; Davies BM; Kotter MR
    Br J Neurosurg; 2022 Jun; 36(3):340-345. PubMed ID: 35132923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existing Funding Sources in Degenerative Cervical Myelopathy Research: Scoping Review.
    Bestwick H; Teh JQ; Mowforth O; Grodzinski B; Kotter M; Davies B
    Interact J Med Res; 2022 Jun; 11(1):e36194. PubMed ID: 35771617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Assessment of Disease Severity and Strategies for Monitoring Progression in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 4].
    Tetreault L; Garwood P; Gharooni AA; Touzet AY; Nanna-Lohkamp L; Martin A; Wilson J; Harrop JS; Guest J; Kwon BK; Milligan J; Arizala AM; Riew KD; Fehlings MG; Kotter MRN; Kalsi-Ryan S; Davies BM
    Global Spine J; 2022 Feb; 12(1_suppl):64S-77S. PubMed ID: 34971524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gathering Global Perspectives to Establish the Research Priorities and Minimum Data Sets for Degenerative Cervical Myelopathy: Sampling Strategy of the First Round Consensus Surveys of AO Spine RECODE-DCM.
    Mowforth OD; Khan DZ; Wong MY; Pickering GAE; Dean L; Magee J; Mullarkey L; Hirayama Y; Rihova M; Butler M; Stewart M; Goulson B; Ahmed S; Fricke K; Popa-Nimigean V; Millar Z; Venkatesh A; Willison A; Senthil K; Hazenbiller O; Sarewitz E; Sadler I; Gronlund T; Tetreault L; Harrop JS; Aarabi B; Rahimi-Movaghar V; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Fehlings MG; McNair AGK; Davies BM; Kotter MRN;
    Global Spine J; 2022 Feb; 12(1_suppl):8S-18S. PubMed ID: 34879754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Top 50 Most-Cited Articles on Cervical Spondylotic Myelopathy.
    Malik AT; Jain N; Yu E; Khan SN
    World Neurosurg; 2018 Aug; 116():e1168-e1180. PubMed ID: 29870842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degenerative cervical myelopathy: Where have we been? Where are we now? Where are we going?
    Hejrati N; Pedro K; Alvi MA; Quddusi A; Fehlings MG
    Acta Neurochir (Wien); 2023 May; 165(5):1105-1119. PubMed ID: 37004568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM).
    Yanez Touzet A; Bhatti A; Dohle E; Bhatti F; Lee KS; Furlan JC; Fehlings MG; Harrop JS; Zipser CM; Rodrigues-Pinto R; Milligan J; Sarewitz E; Curt A; Rahimi-Movaghar V; Aarabi B; Boerger TF; Tetreault L; Chen R; Guest JD; Kalsi-Ryan S; McNair AG; Kotter M; Davies B;
    BMJ Open; 2022 Jan; 12(1):e057650. PubMed ID: 35046007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery priorities in degenerative cervical myelopathy: a cross-sectional survey of an international, online community of patients.
    Davies B; Mowforth O; Sadler I; Aarabi B; Kwon B; Kurpad S; Harrop JS; Wilson JR; Grossman R; Fehlings MG; Kotter M
    BMJ Open; 2019 Oct; 9(10):e031486. PubMed ID: 31601597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of metabolic disease in degenerative cervical myelopathy: a systematic review.
    Partha Sarathi CI; Sinha A; Rafati Fard A; Bhatti F; Rujeedawa T; Ahmed S; Akhbari M; Bhatti A; Nouri A; Kotter MR; Davies BM; Mowforth OD
    Front Neurol; 2024; 15():1301003. PubMed ID: 38375465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can co-authorship networks be used to predict author research impact? A machine-learning based analysis within the field of degenerative cervical myelopathy research.
    Grodzinski N; Grodzinski B; Davies BM
    PLoS One; 2021; 16(9):e0256997. PubMed ID: 34473796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of lived experience-centered word clouds to support research uncertainty gathering in degenerative cervical myelopathy: results from an engagement process and protocol for their evaluation, via a nested randomized controlled trial.
    Davies BM; Mowforth OD; Khan DZ; Yang X; Stacpoole SRL; Hazenbiller O; Gronlund T; Tetreault L; Kalsi-Ryan S; Starkey ML; Sadler I; Sarewitz E; Houlton D; Carter J; Howard E; Rahimi-Movaghar V; Guest JD; Aarabi B; Kwon BK; Kurpad SN; Harrop J; Wilson JR; Grossman R; Smith EK; McNair AGK; Fehlings MG; Kotter MRN
    Trials; 2021 Jun; 22(1):415. PubMed ID: 34172080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation.
    Witiw CD; Tetreault LA; Smieliauskas F; Kopjar B; Massicotte EM; Fehlings MG
    Spine J; 2017 Jan; 17(1):15-25. PubMed ID: 27793760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic repetitive Transcranial Magnetic stimulation (rTMS) for neurological dysfunction in Degenerative cervical Myelopathy: An unexplored opportunity? Findings from a systematic review.
    Gharooni AA; Khan M; Yang X; Anwar F; Davies B; Kotter M
    J Clin Neurosci; 2021 Aug; 90():76-81. PubMed ID: 34275584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RE-CODE DCM (
    Davies BM; Khan DZ; Mowforth OD; McNair AGK; Gronlund T; Kolias AG; Tetreault L; Starkey ML; Sadler I; Sarewitz E; Houlton D; Carter J; Kalsi-Ryan S; Aarabi B; Kwon BK; Kurpad SN; Harrop J; Wilson JR; Grossman R; Curt A; Fehlings MG; Kotter MRN
    Global Spine J; 2019 May; 9(1 Suppl):65S-76S. PubMed ID: 31157148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Nutrition in Degenerative Cervical Myelopathy: A Systematic Review.
    Partha Sarathi CI; Mowforth OD; Sinha A; Bhatti F; Bhatti A; Akhbari M; Ahmed S; Davies BM
    Nutr Metab Insights; 2021; 14():11786388211054664. PubMed ID: 34733105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a MEDLINE search filter/hedge for degenerative cervical myelopathy.
    Davies BM; Goh S; Yi K; Kuhn I; Kotter MRN
    BMC Med Res Methodol; 2018 Jul; 18(1):73. PubMed ID: 29976134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic review.
    Grodzinski B; Durham R; Mowforth O; Stubbs D; Kotter MRN; Davies BM
    Age Ageing; 2021 May; 50(3):705-715. PubMed ID: 33219816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.